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ABSTRACT
Tissue hypoxia is the central pathophysiological  process in shock and an important co-factor in the development of organ 
dysfunction. Hemodynamic parameters, usually used to assess the perfusion of organs and tissues, like  arterial blood 
pressure, heart rate, urine output and blood gases can be normal in the presence of tissue hypoxia and cannot rule out 
imbalances between global oxygen supply and demand. Mixed venous oxygen saturation (SvO2) is a sensitive indicator 
of the adequacy of whole-body tissue oxygenation. However, it requires the placement of a pulmonary artery catheter, 
which is an invasive procedure with the possibility of numerous complications and is increasingly questioned due to the 
lack of evidence that it improves outcome. Central venous oxygen saturation (ScvO2) requires the insertion of a central 
venous catheter, which is routinely used in most critically ill patients, but it reflects the adequacy of oxygenation in the brain 
and upper part of the body and differs from SvO2.  Still, it can be used as a surrogate for mixed venous oxygen saturation 
because the changes and trends of both variables parallel  each other.  Both variables are used extensively in the treatment 
of patients with severe sepsis, shock and trauma. In combination with other hemodynamic and biochemical parameters, 
they have diagnostic and prognostic value and allow for rational treatment of critically ill patients.
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The basic role of the cardiorespiratory 
system is to supply oxygen to the tis-
sues. The reduction of oxygen availabil-
ity to the tissues, on a global or regional 
scale is the most frequent cause of 
physiological decompensation. The 
other, less frequent, causes are defi-
cit in glucose supply, accumulation 
of metabolic waste products (carbon 
dioxide and lactate) and metabolic poi-
soning which interferes with the cellular 
utilization of oxygen (carbon monoxide, 
cyanide and possibly sepsis). 
The oxygen partial pressure at mito-
chondrial level would be the ideal vari-
able to monitor but it is impossible in the 
clinical setting. The more practical way 
of gaining an insight into the balance 
between oxygen supply and demand 
is  measurement of  venous oxygen 
saturation. A rise in venous saturation 
indicates a rise in supply relative to 
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demand and a fall in venous satura-
tion indicates the opposite. Readings 
of venous oxymetry may be monitored 
continuously with a fibreoptic catheter 
(1)  or intermittently by blood sampling 
and co-oxymetry. Fibreoptic monitoring 
is based on the presence of an optical 
fibre built into the catheter for meas-
uring hemoglobin saturation. Light is 
transmitted into the blood, reflected off 
red blood cells and read by a photo 
detector. Continuous monitoring allows 
for prompt detection in changes of oxy-
gen saturation and for easy observation 
of trends. The sampling method is more 
feasible and may be used in intensive 
care unit (ICU) patients or outside the 
ICU setting.
Recently, an alternative method for mea-
suring mixed venous saturation was 
described where the oxymeter probe 
was placed in the trachea of anesthe-
tized  patients, adjacent to the pulmo-
nary artery. The readings had excellent 
correlation with readings determined by 
co-oximetry from samples taken simul-
taneously from the pulmonary artery (2)
Venous oxygen saturation may be used 
to monitor individual organs, like the brain 
in a head trauma patient, by placing a 
catheter in the internal jugular vein. More 
commonly, it is used to monitor the glo-
bal oxygen balance by catheter place-
ment in the pulmonary artery or central 
vein. However, the global oxygen balance 
does not necessarily reflect the oxygena-
tion status of individual organs (3)     
When taking blood samples, blood 
needs to be aspirated very slowly 
because high negative pressures in the 
syringe can lower gas tensions and may 
lead to air entering the sample. When 
fibreoptic monitoring is used there is 
a possibility of interference from other 
optically active compounds (carboxy-
hemoglobin, very high bilirubin levels). 
There is also the need for recalibration 




Venous oxymetry reflects the balance 
between oxygen supply or delivery 
(DO2) and oxygen consumption (VO2). 
DO2 is dependent on cardiac output 
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(CO) and oxygen content in  arterial 
blood (CaO2) which is the sum of oxy-
gen bound to hemoglobin product of 
hemoglobin concentration (Hb)  and 
arterial O2 saturation (SaO2)] and 
physically dissolved oxygen (PaO2), 
according to the following formulas: 
DO2 = CO x CaO2
CaO2 = (Hb x 1,36 x SaO2) + (PaO2 
x 0,0031)
The amount of physically dissolved oxy-
gen is small and can be neglected for 
practical purposes. Thus, oxygen deliv-
ery is defined mostly by CO, Hb and 
SaO2. Clinical conditions that can affect 
DO2 are low cardiac output, anemia 
and hypoxia (decreased DO2) and high 
cardiac output or CaO2 which increase 
DO2 (Table 1).  
Oxygen demand or whole-body oxygen 
consumption (VO2) can be expressed 
by the product of CO and arteriovenous 
O2 content difference (CaO2 – CvO2) 
which is known as the Fick principle:
VO2 = CO x (CaO2 – CvO2) or rear-
ranged
CvO2 = CaO2 – VO2 / CO
That means that mixed venous oxy-
gen content (CvO2) reflects the rela-
tion between whole body oxygen con-
sumption and cardiac output under 
conditions of constant CaO2. CvO2 can 
also be expressed by the equation:
CvO2 = (Hb x 1,36 x SvO2) + (PvO2 
x 0,0031)
As physically dissolved oxygen can be 
neglected, the principal determinants 
of CvO2 are Hb and SvO2. Since Hb 
is usually constant in a certain period 
of time, CvO2 is mostly determined by 
SvO2. SvO2 is inversely related to the 
VO2 / CO ratio. Clinical conditions that 
can affect VO2 are stress, pain, hyper-
thermia and shivering (increase O2 
consumption) or analgesia, sedation, 
mechanical ventilation and hypother-
mia which decrease O2 consumption 
(Table 1). 
Oxygen delivery and consumption are 
linked by a simple relationship:
VO2 = DO2 x ERO2     or      
ERO2 = VO2 / DO2
where ERO2 represents oxygen extrac-
tion ratio as a percentage. Normally 
ERO2 is about 25%  which means that 
25% of delivered oxygen is taken up by 
tissues and 75%  returns to the lungs. 
ERO2 is inversely related to SvO2, 
which is shown in the equation:
SvO2 = 1 – ERO2 
Therefore, normal ERO2 of 25% corre-
sponds to SvO2 of 75%, and ERO2 of 60 
% matches SvO2  of 40%. Under normal 
conditions VO2 is independent of DO2 
because tissues can meet their needs 
for oxygen by increasing  extraction. 
When this compensation is exhausted at 
critical DO2, VO2 becomes dependent 
of DO2. Anaerobic metabolism occurs 
and lactates begin to rise.
Oxygen delivery and consumption vary 
during physiological (exercise) and 
clinical conditions. The normal cardio-
vascular response to increasing VO2 
is to increase ERO2 and cardiac out-
put.  SvO2 normally decreases during 
exercise because the increased car-
diac output cannot match completely 
the increased O2 demand. Therefore, a 
drop in SvO2 does not necessarily mean 
that tissue hypoxia is occurring but rep-
resents increased metabolic stress. 
The extent of the SvO2 drop denotes the 
magnitude of the stress (4) (Table 2). 
In a healthy person anaerobic metabo-
lism usually occurs when SvO2 drops 
below 40% for a substantial period of 
time. In patients with severe heart dis-
ease the ERO2 is increased at rest and 
they can live with SvO2 in the low range 
without apparent hypoxia because they 
have adapted to hypoxia (rightward shift 
of oxyhemoglobin dissociation curve, 
adaptation of peripheral microvascula-
ture).  
In a septic patient misdistribution of 
blood flow and the disturbance of mito-
chondrial oxygen utilization may cause 
anaerobic metabolism in the presence 
of normal or even high SvO2. In that 
case blood lactate levels and base defi-
cit will be high. 
The normal values of SvO2 are con-
sidered to be between 60 and 80%. 
Examples from above show that SvO2 
values should be interpreted carefully 
in the context of a wider clinical and 
biochemical picture. 
The relationship 




Obtaining mixed venous oxygen satu-
ration levels requires pulmonary artery 
catheterization with a risk-benefit rela-
tionship that is still a matter of contro-
versy. Central venous oxygen satura-
tion may be obtained through a central 
venous catheter which is commonly 
placed in critically ill patients for a vari-
ety of reasons like central venous pres-
sure monitoring, parenteral nutrition 
and catecholamine infusion.  Therefore, 
          Decrease in SvO2/ScvO2                    Increase in SvO2/ScvO2
O2 consumption      O2 delivery          O2 consumption        O2 delivery 
- anemia
- hypoxia






- high CaO2 
- high CO
-  stress
-  pain 
-  hyperthermia
-  shivering 
 Table 1: Clinical conditions that affect DO2, VO2 and venous oxymetry
ScvO2 measurement seems to be an 
attractive alternative to SvO2 monitor-
ing. However, it has been questioned 
whether ScvO2 may be used instead of 
SvO2 especially under various clinical 
conditions.    
There are normal, physiological dif-
ferences between SvO2 and ScvO2. 
Venous oxygen saturation differs among 
organ systems  because they extract dif-
ferent amounts of oxygen.  
The central venous catheter tip resides 
in the superior vena cava which col-
lects blood from the brain and upper 
part of the body. The pulmonary artery 
catheter sampling site is in the pulmo-
nary artery which collects mixed venous 
blood that drains from the whole body. 
The blood that drains from the lower 
part of the body into the inferior vena 
cava has a higher venous saturation 
level than the blood  in the superior 
vena cava mostly due to highly satu-
rated (92%) renal venous blood. Renal 
blood flow uses blood for non- oxyda-
tive phosphorylation needs and oxygen 
extraction is relatively low. Since the 
pulmonary artery contains a mixture 
of blood from both the superior and 
inferior vena cava, SvO2 is greater than 
ScvO2 by about 2-3%.(5) 
The tip of the central venous catheter 
may also be positioned in the right 
atrium or at the junction of the superior 
vena cava and right atrium. Further-
more, the catheter can  move due to a 
change in position of the patient (6) The 
sampled blood may contain, to some 
degree, blood from the inferior vena 
cava which can decrease the difference 
between SvO2 and ScvO2. 
The relationship between the two vari-
ables may also be affected by various 
clinical situations and has been investi-
gated in many experimental and clinical 
studies with different conclusions.
Several studies demonstrated the rever-
sed relationship of SvO2 and ScvO2 in 
shock (7,8). 
During cardiogenic and hypovolem-
ic shock mesenteric and renal flow 
decreases followed by an increase in 
oxygen extraction. During septic shock, 
regional oxygen consumption by the 
gastrointestinal tract increases to a 
greater extent than blood flow.  In both 
situations the blood in the inferior vena 
cava is desaturated and SvO2 is lower 
than ScvO2. Thus, during shock the low 
ScvO2 implies even lower SvO2. The 
difference is 5-18% (9), and a ScvO2 
value of 50% is considered critical.      
During anesthesia ScvO2 also exceeds 
SvO2 by up to 6% due to the effects of 
inhalational anesthetics which increase 
cerebral blood flow and decrease oxy-
gen extraction in the brain. (10) 
A similar effect can be induced by cere-
bral trauma and barbiturate coma. Pati-
ents with elevated intracranial pressure 
have the highest difference between 
SvO2 and ScvO2 (11)     
There has been considerable debate 
about whether ScvO2 may substitute 
SvO2 due to considerable differences. 
Edwards et al. in their prospective clini-
cal investigation (12), compared oxyhe-
moglobin saturation in blood samples 
taken only once during insertion of the 
pulmonary artery catheter  from the 
superior vena cava, right atrium and 
pulmonary artery in thirty consecutive 
patients in severe shock. They found 
no statistical correlation between single 
measurements.     
Reinhart et al. (13) examined the cor-
relation between SvO2 and ScvO2 over 
a broad range of cardiorespiratory 
conditions in anesthetized dogs. The 
SvO2 and ScvO2 values and chang-
es in values induced by experimental 
interventions were generally in close 
accordance throughout all of the exper-
imental conditions. The same author, 
in another clinical study (11), explored 
the course of continuous and parallel 
measurements of SvO2 and ScvO2 in 
high risk patients in an interdisciplinary 
ICU. The results of this study confirmed 
the findings of others,  namely that in 
patients with circulatory failure, ScvO2 
is generally higher than SvO2, but also 
that changes in values were parallel in 
direction and similar in size.      
Dueck et al. (14), in a prospective clini-
cal trial, compared the oxyhemoglobin 
saturation in  blood from the superior 
vena cava, right atrium and pulmonary 
artery during various hemodynamic sit-
uations. Correlation between single val-
ues was interpreted as clinically unac-
ceptable, whereas, correlation between 
changes of oxygen saturation at various 
sampling sites was interpreted as clini-
cally acceptable.     
From these and other studies it may 
be concluded that there is an incon-
stant difference between absolute val-
ues of SvO2 and ScvO2 during shock, 
anesthesia and cerebral trauma and 
ScvO2 cannot be used instead of SvO2 
for calculation of derived variables like 
oxygen consumption, extraction ratio 
or pulmonary shunt. The changes and 
trends of SvO2 are closely mirrored by 
changes in ScvO2 and there is paral-
lel tracking of both variables during 
various hemodynamic conditions.  The 
presence of a pathologically low ScvO2 
(implying an even lower SvO2) is more 
clinically important than whether the 
values are equal. That makes ScvO2 
a satisfactory substitute for SvO2 in a 
hemodynamically unstable patient.
Table 2: The magnitude of SvO2 
drop related to physiological conse-
quences
SvO2  Oxygenation status 
> 75%  Normal extraction 
  DO2>VO2
75-50%  Increasing VO2 or   
  decreasing DO2
  Compensatory 
  O2 extraction
50-30%  Exhausting of   
  extraction
  Beginning of lactic  
  acidosis
  DO2<VO2
30-25%  Severe lactic 
  acidosis
< 25%  Cellular death
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applied  during the first hours after 
admission it is difficult to draw conclu-
sions regarding the quality of venous 
oxymetry from this study.    
The beneficial effect of continuous 
measurement of ScvO2 was demon-
strated by Rivers et al. in a prospec-
tive randomized study in patients with 
severe sepsis and septic shock (17). It 
was used as a hemodynamic goal  dur-
ing early and aggressive resuscitation. 
The maintenance of  ScvO2 above 70% 
in addition to maintaining mean arte-
rial blood pressure above 65 mmHg, 
central venous pressure between 8-
12 mmHg and urine output above 0,5 
ml/kg/h reduced absolute mortality by 
15%. In this study ScvO2 was moni-
tored fibreoptically. 
Whether intermittent sampling would 
have had the same results remains to 
be demonstrated. The results of this 
important study are incorporated in the 
Surviving Sepsis campaign guidelines. 
The care of severely traumatized 
patients includes early and aggressive 
resuscitation followed by early surgical 
intervention. Studies have shown that 
vital signs like blood pressure, heart rate 
and central venous pressure are insensi-
tive end-points and that 50% of patients 
had insufficient ScvO2 after initial resus-
citation. (18) Patients with ScvO2 lower 
than 65% after initial resuscitation need-
ed additional interventions. The same 
cut-off value was able to detect initially 
hemodynamically stable patients in 
need of blood transfusion. (19)   
Heart failure is a state of limited cardiac 
output. Therefore, such patients can-
not sufficiently increase cardiac out-
put during a rise of oxygen demand. 
Those changes can only be covered 
by increasing O2 extraction. Therefore, 
in these patients SvO2 is tightly cor-
related with cardiac output and a drop 
in SvO2 is a good marker of cardiac 
deterioration. 
Those patients can live with low SvO2 
values without tissue hypoxia, and the 
rise of lactate may be the first sign 
of decompensation. Patients with an 
ScvO2 below 60% are usually in  cardio-
genic shock (20)   
ScvO2 has been shown to have diag-
nostic, prognostic and therapeutic use 
in patients who have an acute myocar-
dial infarction (15,21)    
Continuous fibreoptic ScvO2 monitor-
ing may be very helpful during cardiop-
ulmonary Resuscitation (CPR). During 
cardiac arrest venous blood is desatu-
rated to very low values  (<20%). Suc-
cessful chest compressions increase 
ScvO2 above 40% (22). It also has 
predictive value: in all patients who 
reached ScvO2 >72% during CPR, 
spontaneous circulation was observed 
(23) In the immediate post resuscitation 
period patients are often hemodynami-
cally unstable. The decrease of ScvO2 
to <40-50% indicates the likelihood of 
re-arrest. Sustained, extreme elevation 
of ScvO2 above 80% is an unfavorable 
predictor of outcome. These very high 
values may be indicative of impairment 
of tissue oxygen utilization (24)    
The successful use of ScvO2 as a 
hemodynamic goal in the management 
of early sepsis has led to interest in 
the use of this parameter in surgical 
patients. Pearse et al. demonstrated 
that applying goal directed therapy in 
the intensive care unit can be success-
fully initiated after major surgery (25) 
During this study they also measured 
ScvO2 in order to assess the efficacy of 
goal directed therapy. The analysis sug-
gests that ScvO2 may have prognostic 
significance after major surgery. In their 
cohort of patients the ScvO2 cut-off 
value of 64,4% discriminated patients 
with a complicated and uncomplicated 
postoperative course (26). 
     
Conclusion
Venous oxymetry gives essential infor-
mation about tissue oxygenation. Mea-
surement of ScvO2 is simple, feasible 
in every ICU and may give almost the 
same information as SvO2. Its value is 
recognized by clinicians and is used 
extensively in various clinical settings. 
It should be interpreted carefully, taking 
into account the complexity of patients 
and diseases, combined with other cli-
nical, hemodynamical and biochemical 
variables.
Clinical application of 
venous oxymetry
When dealing with hemodynamically 
unstable patients in ICU the treatment is 
usually centered on optimizing cardiac 
output. At the beginning of resuscitation 
the clinician relies on hemodynamic 
variables like arterial blood pressure, 
central venous pressure, urine output 
and arterial blood gases which can 
all be normal despite tissue hypoxia. 
When cardiac output is monitored, usu-
ally by transpulmonary or transarte-
rial thermodilution  insight into only half 
of the picture is obtained, i.e. oxygen 
delivery. The relationship between oxy-
gen delivery and oxygen consumption 
cannot be seen from cardiac output 
alone. High cardiac output values dur-
ing severe sepsis and septic shock may 
be associated with tissue hypoxia.      
Venous oxygen saturation provides 
information about the second part of 
the picture – adequacy of oxygen sup-
ply. Monitoring of SvO2 and ScvO2, 
together with other hemodynamic and 
biochemical variables, allows for a 
rational approach to the management 
of critically ill patients. Measures may be 
undertaken to increase DO2 by increas-
ing cardiac output, Hb or PaO2. In the 
same time VO2 may be decreased by 
sedation, analgesia, antipyretics and 
mechanical ventilation.      
Target SvO2 depends on the clinical sit-
uation. In high output states it is higher 
(SvO2 70%) but in low-output states it is 
lower and usually 60% is accepted.      
The importance of SvO2 monitoring has 
been originally proposed in cardiology 
patients. (15) Since then, indications for 
this monitoring have extended to other 
areas and it was used extensively in 
various clinical scenarios.     
Gattinoni et al. in a large multicentre trial 
(16) resuscitated critically ill patients to 
an SvO2 >70% and could not find any 
difference in morbidity and mortality 
between treated and control patients. 
However, the anticipated goal was only 
achieved in one third of the patients and 
who were included only 48 hours after 
admission to the ICU. Since hemody-
namic resuscitation should have been 
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